Charles Schwab’s Aldeyra Therapeutics ALDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$603K Buy
157,538
+19,553
+14% +$74.9K ﹤0.01% 3076
2025
Q1
$793K Buy
137,985
+1,252
+0.9% +$7.2K ﹤0.01% 2923
2024
Q4
$682K Hold
136,733
﹤0.01% 3047
2024
Q3
$737K Hold
136,733
﹤0.01% 3018
2024
Q2
$453K Buy
136,733
+11,208
+9% +$37.1K ﹤0.01% 3240
2024
Q1
$410K Hold
125,525
﹤0.01% 3098
2023
Q4
$441K Hold
125,525
﹤0.01% 3122
2023
Q3
$839K Hold
125,525
﹤0.01% 2859
2023
Q2
$1.05M Buy
125,525
+103,324
+465% +$867K ﹤0.01% 2755
2023
Q1
$220K Hold
22,201
﹤0.01% 3136
2022
Q4
$155K Hold
22,201
﹤0.01% 3220
2022
Q3
$119K Hold
22,201
﹤0.01% 3210
2022
Q2
$89K Sell
22,201
-110,707
-83% -$444K ﹤0.01% 3298
2022
Q1
$591K Buy
132,908
+4,523
+4% +$20.1K ﹤0.01% 3050
2021
Q4
$514K Buy
128,385
+3,699
+3% +$14.8K ﹤0.01% 3135
2021
Q3
$1.1M Sell
124,686
-413
-0.3% -$3.63K ﹤0.01% 2841
2021
Q2
$1.42M Buy
125,099
+106,972
+590% +$1.21M ﹤0.01% 2819
2021
Q1
$216K Hold
18,127
﹤0.01% 3304
2020
Q4
$125K Hold
18,127
﹤0.01% 3301
2020
Q3
$135K Buy
+18,127
New +$135K ﹤0.01% 3228
2020
Q2
Sell
-52,683
Closed -$131K 3320
2020
Q1
$131K Sell
52,683
-4,964
-9% -$12.3K ﹤0.01% 3079
2019
Q4
$335K Buy
57,647
+4,111
+8% +$23.9K ﹤0.01% 2951
2019
Q3
$283K Sell
53,536
-8,000
-13% -$42.3K ﹤0.01% 2979
2019
Q2
$370K Buy
61,536
+19,826
+48% +$119K ﹤0.01% 2950
2019
Q1
$377K Sell
41,710
-5,100
-11% -$46.1K ﹤0.01% 2863
2018
Q4
$389K Buy
46,810
+17,110
+58% +$142K ﹤0.01% 2847
2018
Q3
$410K Hold
29,700
﹤0.01% 2907
2018
Q2
$237K Buy
+29,700
New +$237K ﹤0.01% 3039